HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Baxter International (BAX) Investors with $100k+ Losses to Contact its Attorneys, Application Deadline ApproachingHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Baxter International (BAX) Investors with $100k+ Losses to Contact its Attorneys, Application Deadline ApproachingGlobeNewswireJanuary 3, 2020ReblogShareTweetShareSAN FRANCISCO, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Baxter International (NYSE: BAX) investors who have suffered losses in excess of $100,000 to submit their losses now to learn if they qualify to recover compensable damages.  The January 24, 2020 lead plaintiff deadline in a securities fraud class action that has been filed against the company and senior executives is fast approaching.Class Period: Feb. 21, 2019 - Oct. 23, 2019Lead Plaintiff Deadline: Jan. 24, 2020Sign Up: www.hbsslaw.com/investor-fraud/BAX Contact An Attorney Now: BAX@hbsslaw.com                                              844-916-0895Baxter International (BAX) Securities Class Action:The complaint alleges that Defendants misled investors by engaging in fraudulent accounting.According to the complaint, Baxter engaged in intra-company transactions to generate foreign exchange gains and losses, used foreign exchange rate conventions that violated generally accepted accounting principles (“GAAP”), and enabled intra-company transactions to be undertaken after the related exchange rates were already known.Baxter investors began to learn the truth when, on Oct. 24, 2019, Baxter disclosed an Audit Committee investigation into the Company’s accounting for certain foreign-currency sales, which violated GAAP and resulted in Baxter misreporting nearly $300 million in net foreign-exchange gains over the past five years.  Baxter said it would not be able to timely file its third quarter 2019 quarterly report.This news drove the price of Baxter shares sharply lower that day. More recently, on Nov. 22, 2019, Baxter disclosed that it had received a notice of noncompliance from the NYSE, threatening to potentially delist the Company should it fail to file its quarterly report and any subsequently delayed filings by May 20, 2020. If you invested in Baxter between Feb. 21, 2019 and Oct. 23, 2019 (the “Class Period”) and suffered significant losses, you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.  Contact Hagens Berman immediately for more information about the case and being a lead plaintiff.“We’re focused on investors’ losses and whether Baxter sought to manufacture profits through shady foreign-currency sales accounting,” said Reed Kathrein, the Hagens Berman partner leading the investigation.If you purchased shares of Baxter and suffered significant losses, click here to discuss your legal rights with Hagens Berman.Whistleblowers: Persons with non-public information regarding Baxter International should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email BAX@hbsslaw.com.About Hagens BermanHagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.Contact:Reed Kathrein, 844-916-0895ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextScotland Is Making Pads & Tampons Free For EveryoneRefinery29Why Earnings Season Could Be Great for Baxter (BAX)ZacksRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance